Categories
Uncategorized

Biogen Accused of Baiting Patients With Illegal Drug Co-Pays

We’ve detected unusual activity from your computer network To continue, please click the

Categories
Uncategorized

Biogen Alzheimer’s Approval Review Ramps Up as ‘Anomalies’ Found

We’ve detected unusual activity from your computer network To continue, please click the

Categories
Biogen Study

Biogen and Eisai Announce Design of ADUHELM ICARE AD-US Study, the First Real-World Observational Phase 4 Study in Alzheimer’s Disease at AAIC 2021

TOKYO, Jul 30, 2021 – (JCN Newswire) – Biogen (Nasdaq: BIIB) and Eisai Co., Ltd. (Tokyo) today announced that Biogen led a late-breaking presentation on the design of the first real-world observational Phase 4 study in Alzheimer’s disease called ICARE AD-US, at the Alzheimer’s Association International Conference (AAIC), being held both virtually and in Denver,…

Categories
Uncategorized

Biogen Blasts Criticism of Alzheimer’s Drug as ‘Misinformation’

We’ve detected unusual activity from your computer network To continue, please click the

Categories
Uncategorized

Biogen Alzheimer’s Drug Subject of New House Committee Probe

We’ve detected unusual activity from your computer network To continue, please click the